A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution

Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitzmann, Edwige, Javelot, Hervé, Weiner, Luisa, Michel, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080510/
https://www.ncbi.nlm.nih.gov/pubmed/27818825
http://dx.doi.org/10.1155/2016/7031245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080510/
https://www.ncbi.nlm.nih.gov/pubmed/27818825
http://dx.doi.org/10.1155/2016/7031245

Ejemplares similares